PL2155258T3 - Ulepszone sposoby wytwarzania hydrazydów - Google Patents
Ulepszone sposoby wytwarzania hydrazydówInfo
- Publication number
- PL2155258T3 PL2155258T3 PL08755945T PL08755945T PL2155258T3 PL 2155258 T3 PL2155258 T3 PL 2155258T3 PL 08755945 T PL08755945 T PL 08755945T PL 08755945 T PL08755945 T PL 08755945T PL 2155258 T3 PL2155258 T3 PL 2155258T3
- Authority
- PL
- Poland
- Prior art keywords
- improved processes
- hydrazides
- making
- making hydrazides
- processes
- Prior art date
Links
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/04—Preparation of hydrazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coating Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93952907P | 2007-05-22 | 2007-05-22 | |
| PCT/US2008/064213 WO2008147765A1 (en) | 2007-05-22 | 2008-05-20 | Improved processes for making hydrazides |
| EP08755945.6A EP2155258B1 (en) | 2007-05-22 | 2008-05-20 | Improved processes for making hydrazides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2155258T3 true PL2155258T3 (pl) | 2017-12-29 |
Family
ID=39810161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12159159T PL2465541T3 (pl) | 2007-05-22 | 2008-05-20 | Ulepszone sposoby wytwarzania hydrazydów |
| PL08755945T PL2155258T3 (pl) | 2007-05-22 | 2008-05-20 | Ulepszone sposoby wytwarzania hydrazydów |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12159159T PL2465541T3 (pl) | 2007-05-22 | 2008-05-20 | Ulepszone sposoby wytwarzania hydrazydów |
Country Status (24)
| Country | Link |
|---|---|
| US (5) | US8110705B2 (pl) |
| EP (2) | EP2465541B1 (pl) |
| JP (4) | JP5697446B2 (pl) |
| KR (1) | KR101547705B1 (pl) |
| CN (2) | CN102558001B (pl) |
| AR (1) | AR066674A1 (pl) |
| AU (1) | AU2008256905B2 (pl) |
| BR (1) | BRPI0811140B1 (pl) |
| CA (1) | CA2687852A1 (pl) |
| CL (1) | CL2008001490A1 (pl) |
| CY (2) | CY1119373T1 (pl) |
| DK (2) | DK2465541T3 (pl) |
| ES (2) | ES2642888T3 (pl) |
| HU (2) | HUE039657T2 (pl) |
| IL (1) | IL202242A (pl) |
| MX (1) | MX2009012587A (pl) |
| PA (1) | PA8781201A1 (pl) |
| PE (1) | PE20090305A1 (pl) |
| PL (2) | PL2465541T3 (pl) |
| PT (2) | PT2155258T (pl) |
| SI (2) | SI2465541T1 (pl) |
| TW (1) | TW200904784A (pl) |
| WO (1) | WO2008147765A1 (pl) |
| ZA (1) | ZA200908229B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811140B1 (pt) * | 2007-05-22 | 2022-08-16 | Wyeth Llc | Processos melhorados para produção de hidrazidas |
| US9902691B2 (en) * | 2013-11-04 | 2018-02-27 | Pfizer Inc. | Intermediates and methods for synthesizing calicheamicin derivatives |
| AR098221A1 (es) | 2013-11-04 | 2016-05-18 | Pfizer | Conjugados de anticuerpo anti-efna4-fármaco |
| SI3137114T1 (sl) | 2014-04-30 | 2021-11-30 | Pfizer Inc. | Konjugati protitelo proti PTK7-zdravilo |
| WO2016105330A1 (en) * | 2014-12-22 | 2016-06-30 | Hewlett Packard Enterprise Development Lp | Response to an inoperative network device managed by a controller |
| WO2019018647A1 (en) | 2017-07-20 | 2019-01-24 | Pfizer Inc. | ANTI-GD3 ANTIBODIES AND CONJUGATES ANTIBODY-MEDICATION |
| EP3693452A4 (en) | 2017-10-03 | 2021-06-23 | University Public Corporation Osaka | CELL CULTURE CONTAINER, CELL ACQUISITION PROCESS AND CELL CULTURE PROCESS |
| CN109574870A (zh) * | 2018-12-25 | 2019-04-05 | 维思普新材料（苏州）有限公司 | 一种酰肼的连续制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US623230A (en) * | 1899-04-18 | Rotary ore-cooler | ||
| US4291022A (en) * | 1975-03-11 | 1981-09-22 | Sandoz Ltd. | Organic compounds |
| DE2608336A1 (de) | 1975-03-11 | 1976-09-30 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4479953A (en) * | 1983-08-25 | 1984-10-30 | Merck & Co., Inc. | Pyrazine aldimine compounds as antimicrobial agents |
| US4970198A (en) | 1985-10-17 | 1990-11-13 | American Cyanamid Company | Antitumor antibiotics (LL-E33288 complex) |
| US4729781A (en) * | 1986-08-04 | 1988-03-08 | Sandoz Ltd. | 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents |
| ES2023217B3 (es) * | 1986-08-04 | 1992-01-01 | Sandoz Ag | Derivados de acido benzohidroxamico. |
| US5079233A (en) | 1987-01-30 | 1992-01-07 | American Cyanamid Company | N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| US4939244A (en) | 1987-01-30 | 1990-07-03 | American Cyanamid Company | Pseudoaglycones of LL-E33288 antibiotics |
| US5770701A (en) | 1987-10-30 | 1998-06-23 | American Cyanamid Company | Process for preparing targeted forms of methyltrithio antitumor agents |
| US5053394A (en) | 1988-09-21 | 1991-10-01 | American Cyanamid Company | Targeted forms of methyltrithio antitumor agents |
| JPH05222044A (ja) | 1991-10-25 | 1993-08-31 | Eastman Kodak Co | ２当量ピラゾロトリアゾールマゼンタカプラーの製造 |
| BR9206803A (pt) * | 1991-11-22 | 1995-05-02 | Uniroyal Chemical Ltd | Derivados inseticidas de fenilhidrazina |
| US5690904A (en) * | 1993-07-12 | 1997-11-25 | Amersham International Plc | Diagnostic radiopharmaceutical compounds (That) |
| US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
| US5403015A (en) * | 1993-12-09 | 1995-04-04 | Forte; Steven L. | Cards and methods for playing casino 21 or blackjack |
| AU3264695A (en) * | 1994-08-23 | 1996-03-14 | Nissan Chemical Industries Ltd. | Pyridine derivative |
| IT1292092B1 (it) | 1997-06-05 | 1999-01-25 | Geange Ltd | Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali |
| AU760688B2 (en) * | 1998-10-16 | 2003-05-22 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for GABA receptors |
| GB0008696D0 (en) * | 2000-04-07 | 2000-05-31 | Merck Sharp & Dohme | Therapeutic agents |
| AU2002313633B2 (en) | 2001-06-08 | 2007-03-01 | Cytovia, Inc. | Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| PL224001B1 (pl) * | 2002-05-02 | 2016-11-30 | Wyeth Corp | Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie |
| US6803379B2 (en) * | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| CN100364531C (zh) * | 2002-12-18 | 2008-01-30 | 西托维亚公司 | 3,5－二取代－[1,2,4]－二唑及类似物和其用途 |
| ES2333008T3 (es) | 2002-12-20 | 2010-02-16 | Glaxo Group Limited | Derivados de benzo(d)azepina para el tratamiento de trastornos neurologicos. |
| US7304161B2 (en) * | 2003-02-10 | 2007-12-04 | Intrexon Corporation | Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| WO2004101512A2 (en) | 2003-05-13 | 2004-11-25 | Smithkline Beecham Corporation | Naphthyridine integrase inhibitors |
| JP2007521287A (ja) | 2003-07-02 | 2007-08-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | 電位依存性イオンチャネルの調節因子として有用なピリミジン |
| WO2005005378A2 (en) | 2003-07-02 | 2005-01-20 | Sugen, Inc. | Indolinone hydrazides as c-met inhibitors |
| SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| WO2005097119A2 (en) * | 2004-04-06 | 2005-10-20 | Semafore Pharmaceuticals, Inc. | Pten inhibitors |
| TW200630106A (en) * | 2004-10-08 | 2006-09-01 | Wyeth Corp | Immunotherapy of autoimmune disorders |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| BRPI0811140B1 (pt) * | 2007-05-22 | 2022-08-16 | Wyeth Llc | Processos melhorados para produção de hidrazidas |
-
2008
- 2008-05-20 BR BRPI0811140-5A patent/BRPI0811140B1/pt active IP Right Grant
- 2008-05-20 DK DK12159159.8T patent/DK2465541T3/en active
- 2008-05-20 CN CN201110434577.XA patent/CN102558001B/zh active Active
- 2008-05-20 DK DK08755945.6T patent/DK2155258T3/en active
- 2008-05-20 CA CA2687852A patent/CA2687852A1/en not_active Abandoned
- 2008-05-20 PT PT87559456T patent/PT2155258T/pt unknown
- 2008-05-20 EP EP12159159.8A patent/EP2465541B1/en active Active
- 2008-05-20 MX MX2009012587A patent/MX2009012587A/es active IP Right Grant
- 2008-05-20 SI SI200831994T patent/SI2465541T1/sl unknown
- 2008-05-20 KR KR1020097026806A patent/KR101547705B1/ko active Active
- 2008-05-20 PL PL12159159T patent/PL2465541T3/pl unknown
- 2008-05-20 JP JP2010509499A patent/JP5697446B2/ja active Active
- 2008-05-20 HU HUE12159159A patent/HUE039657T2/hu unknown
- 2008-05-20 CN CN2008800216526A patent/CN101835494B/zh active Active
- 2008-05-20 AU AU2008256905A patent/AU2008256905B2/en active Active
- 2008-05-20 PE PE2008000869A patent/PE20090305A1/es not_active Application Discontinuation
- 2008-05-20 EP EP08755945.6A patent/EP2155258B1/en active Active
- 2008-05-20 HU HUE08755945A patent/HUE036704T2/hu unknown
- 2008-05-20 PT PT12159159T patent/PT2465541T/pt unknown
- 2008-05-20 PL PL08755945T patent/PL2155258T3/pl unknown
- 2008-05-20 US US12/123,777 patent/US8110705B2/en active Active
- 2008-05-20 SI SI200831859T patent/SI2155258T1/sl unknown
- 2008-05-20 ES ES08755945.6T patent/ES2642888T3/es active Active
- 2008-05-20 ES ES12159159.8T patent/ES2686019T3/es active Active
- 2008-05-20 WO PCT/US2008/064213 patent/WO2008147765A1/en not_active Ceased
- 2008-05-22 AR ARP080102165A patent/AR066674A1/es unknown
- 2008-05-22 CL CL200801490A patent/CL2008001490A1/es unknown
- 2008-05-22 TW TW097118930A patent/TW200904784A/zh unknown
- 2008-05-22 PA PA20088781201A patent/PA8781201A1/es unknown
-
2009
- 2009-11-19 IL IL202242A patent/IL202242A/en active IP Right Grant
- 2009-11-20 ZA ZA200908229A patent/ZA200908229B/xx unknown
-
2012
- 2012-01-27 US US13/360,220 patent/US8383857B2/en active Active
-
2013
- 2013-01-31 US US13/755,886 patent/US8853451B2/en active Active
- 2013-08-23 JP JP2013172956A patent/JP2013234203A/ja not_active Withdrawn
-
2014
- 2014-10-02 US US14/504,738 patent/US9227924B2/en active Active
-
2015
- 2015-11-06 JP JP2015218118A patent/JP2016026219A/ja not_active Withdrawn
- 2015-12-18 US US14/973,869 patent/US9738602B2/en active Active
-
2017
- 2017-08-03 JP JP2017150482A patent/JP2017193584A/ja active Pending
- 2017-09-20 CY CY20171100991T patent/CY1119373T1/el unknown
-
2018
- 2018-08-13 CY CY181100854T patent/CY1120592T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0715101D0 (en) | Process | |
| EP2123631A4 (en) | PROCESS FOR PRODUCTION OF -ALCOXYPROPIONAMIDE | |
| GB0706978D0 (en) | Process | |
| GB0711624D0 (en) | Process | |
| GB0716126D0 (en) | Process | |
| GB0714602D0 (en) | Process | |
| GB0711680D0 (en) | Process | |
| ZA200908229B (en) | Improved processes for making hydrazides | |
| GB0700074D0 (en) | process | |
| GB0714390D0 (en) | Process | |
| PL2173197T3 (pl) | Sposób | |
| GB0716783D0 (en) | New Process | |
| GB0700878D0 (en) | Process | |
| GB201003018D0 (en) | Process | |
| GB0724716D0 (en) | Process | |
| GB0724232D0 (en) | Process | |
| PL2152091T5 (pl) | Sposób | |
| GB0719251D0 (en) | Process | |
| GB0701966D0 (en) | Process | |
| GB0722591D0 (en) | Process | |
| GB0720119D0 (en) | Process | |
| GB0714619D0 (en) | Process | |
| GB0725035D0 (en) | Process | |
| GB0707287D0 (en) | Process | |
| GB0705164D0 (en) | Process |